Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
24,088,481
-
Share change
-
+553,054
-
Total reported value
-
$68,671,126
-
Put/Call ratio
-
32%
-
Price per share
-
$2.85
-
Number of holders
-
64
-
Value change
-
+$1,308,655
-
Number of buys
-
26
-
Number of sells
-
25
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2020
As of 30 Sep 2020,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,088,481 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, 5AM Venture Management, LLC, Omega Fund Management, LLC, BlackRock Inc., INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ALETHEA CAPITAL MANAGEMENT, LLC, and Opaleye Management Inc..
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.